Peter Diamandis, X Prize Foundation/Human Longevity Inc., and Jim O'Neill, Mithril Capital Management, join George Church, Harvard/MIT, as keynote speakers at the Rejuvenation Biotechnology Conference.

Thomas Hunt, who first joined SRF's lab as a volunteer aged only 13, has received a $100,000 Thiel Foundation "20 Under 20" fellowship to support his work at the Research Center on telomerase-negative cancer therapy. Thomas discusses his progress and plans in this video.

The brochure and full agenda for Rejuvenation Biotechnology 2014, SRF's upcoming conference in Santa Clara, CA, is now available to download on the conference site. Find out about the expert speakers and entertainment on offer!

In this presentation from TEDxOxbridge on May 17 2014, Dr. Aubrey de Grey explains how 'aging' and age-related disease are just different ways of looking at life-long damage accumulation - and the implications of this for future biomedical therapies.

This year, 15 Summer Scholars will be conducting research at 6 different research institutions. Over the next few months, you’ll have the opportunity to learn more about each scholar and the research he or she will be conducting in the Education Blog.

The BBC's Stephen Sackur, presenter of HARDtalk, interviews SRF's chief science officer Dr. Aubrey de Grey on rejuvenation biotechnology and its social consequences. What will it be like to not know if a stranger is 25 — or 225?

SRF asked world-renowned researchers to participate in a series of lecture videos explaining how regenerative medicine can help treat and prevent the diseases of aging. The complete series of ten lectures is now available.

SRF is pleased to offer the first of many new SENS6 video presentations, covering topics from lysosomal enhancement and single-cell epigenetics to the obstacles facing translational research in aging. Check back frequently for new updates.

In the SENS6 conference’s keynote address, Harvard’s Dr. George Church provides an exciting overview of recent advances in genomic technologies and outlines a bold vision for the future.

Larry Page has announced that Apple and Genentech chair Art Levinson will lead Calico, a Google initiative focused on challenges of age-related disease. TIME asked SRF CSO Aubrey de Grey for his take, posted in conjunction with the breaking news.

Learn why intern Ali Crampton loves to skate and do SENS research, then meet the rest of SRF's Summer 2013 class by watching our new intern spotlight videos. These are just some of the materials featured on our all-new video page, which you can check out here.

SENS Research Foundation is pleased to present our most recent Research Report, providing detailed updates on the progress of our growing portfolio of intramural and extramural projects.

We are honored to welcome Dr. George Church, Professor of Genetics at Harvard Medical School and Director of the NIH Center for Excellence in Genomic Science, to our Research Advisory Board. You can watch his recent SENS6 talk on our new video page here.

In Nature Medicine, SENS Research Foundation-funded PhD student David Brindley discusses the need for robust standards at every stage of the lab-to-clinic pipeline to speed and strengthen the use of genomic data in therapeutics.

In this interview, Dr. de Grey discusses SRF's approach to treating the diseases of aging, and how it differs from most of the research being done today in gerontology. He also talks about his own background, and how he came to the field.

Peter Diamandis, X Prize Foundation/Human Longevity Inc., and Jim O'Neill, Mithril Capital Management, join George Church, Harvard/MIT, as keynote speakers at the Rejuvenation Biotechnology Conference.

Thomas Hunt, who first joined SRF's lab as a volunteer aged only 13, has received a $100,000 Thiel Foundation "20 Under 20" fellowship to support his work at the Research Center on telomerase-negative cancer therapy. Thomas discusses his progress and plans in this video.

The brochure and full agenda for Rejuvenation Biotechnology 2014, SRF's upcoming conference in Santa Clara, CA, is now available to download on the conference site. Find out about the expert speakers and entertainment on offer!

In this presentation from TEDxOxbridge on May 17 2014, Dr. Aubrey de Grey explains how 'aging' and age-related disease are just different ways of looking at life-long damage accumulation - and the implications of this for future biomedical therapies.

This year, 15 Summer Scholars will be conducting research at 6 different research institutions. Over the next few months, you’ll have the opportunity to learn more about each scholar and the research he or she will be conducting in the Education Blog.

The BBC's Stephen Sackur, presenter of HARDtalk, interviews SRF's chief science officer Dr. Aubrey de Grey on rejuvenation biotechnology and its social consequences. What will it be like to not know if a stranger is 25 — or 225?

SRF asked world-renowned researchers to participate in a series of lecture videos explaining how regenerative medicine can help treat and prevent the diseases of aging. The complete series of ten lectures is now available.

SRF is pleased to offer the first of many new SENS6 video presentations, covering topics from lysosomal enhancement and single-cell epigenetics to the obstacles facing translational research in aging. Check back frequently for new updates.

In the SENS6 conference’s keynote address, Harvard’s Dr. George Church provides an exciting overview of recent advances in genomic technologies and outlines a bold vision for the future.

Larry Page has announced that Apple and Genentech chair Art Levinson will lead Calico, a Google initiative focused on challenges of age-related disease. TIME asked SRF CSO Aubrey de Grey for his take, posted in conjunction with the breaking news.

Learn why intern Ali Crampton loves to skate and do SENS research, then meet the rest of SRF's Summer 2013 class by watching our new intern spotlight videos. These are just some of the materials featured on our all-new video page, which you can check out here.

SENS Research Foundation is pleased to present our most recent Research Report, providing detailed updates on the progress of our growing portfolio of intramural and extramural projects.

We are honored to welcome Dr. George Church, Professor of Genetics at Harvard Medical School and Director of the NIH Center for Excellence in Genomic Science, to our Research Advisory Board. You can watch his recent SENS6 talk on our new video page here.

In Nature Medicine, SENS Research Foundation-funded PhD student David Brindley discusses the need for robust standards at every stage of the lab-to-clinic pipeline to speed and strengthen the use of genomic data in therapeutics.

In this interview, Dr. de Grey discusses SRF's approach to treating the diseases of aging, and how it differs from most of the research being done today in gerontology. He also talks about his own background, and how he came to the field.

Peter Diamandis, X Prize Foundation/Human Longevity Inc., and Jim O'Neill, Mithril Capital Management, join George Church, Harvard/MIT, as keynote speakers at the Rejuvenation Biotechnology Conference.

Thomas Hunt, who first joined SRF's lab as a volunteer aged only 13, has received a $100,000 Thiel Foundation "20 Under 20" fellowship to support his work at the Research Center on telomerase-negative cancer therapy. Thomas discusses his progress and plans in this video.

The brochure and full agenda for Rejuvenation Biotechnology 2014, SRF's upcoming conference in Santa Clara, CA, is now available to download on the conference site. Find out about the expert speakers and entertainment on offer!

In this presentation from TEDxOxbridge on May 17 2014, Dr. Aubrey de Grey explains how 'aging' and age-related disease are just different ways of looking at life-long damage accumulation - and the implications of this for future biomedical therapies.

This year, 15 Summer Scholars will be conducting research at 6 different research institutions. Over the next few months, you’ll have the opportunity to learn more about each scholar and the research he or she will be conducting in the Education Blog.

The BBC's Stephen Sackur, presenter of HARDtalk, interviews SRF's chief science officer Dr. Aubrey de Grey on rejuvenation biotechnology and its social consequences. What will it be like to not know if a stranger is 25 — or 225?

SRF asked world-renowned researchers to participate in a series of lecture videos explaining how regenerative medicine can help treat and prevent the diseases of aging. The complete series of ten lectures is now available.

SRF is pleased to offer the first of many new SENS6 video presentations, covering topics from lysosomal enhancement and single-cell epigenetics to the obstacles facing translational research in aging. Check back frequently for new updates.

In the SENS6 conference’s keynote address, Harvard’s Dr. George Church provides an exciting overview of recent advances in genomic technologies and outlines a bold vision for the future.

Larry Page has announced that Apple and Genentech chair Art Levinson will lead Calico, a Google initiative focused on challenges of age-related disease. TIME asked SRF CSO Aubrey de Grey for his take, posted in conjunction with the breaking news.

Learn why intern Ali Crampton loves to skate and do SENS research, then meet the rest of SRF's Summer 2013 class by watching our new intern spotlight videos. These are just some of the materials featured on our all-new video page, which you can check out here.

SENS Research Foundation is pleased to present our most recent Research Report, providing detailed updates on the progress of our growing portfolio of intramural and extramural projects.

We are honored to welcome Dr. George Church, Professor of Genetics at Harvard Medical School and Director of the NIH Center for Excellence in Genomic Science, to our Research Advisory Board. You can watch his recent SENS6 talk on our new video page here.

In Nature Medicine, SENS Research Foundation-funded PhD student David Brindley discusses the need for robust standards at every stage of the lab-to-clinic pipeline to speed and strengthen the use of genomic data in therapeutics.

In this interview, Dr. de Grey discusses SRF's approach to treating the diseases of aging, and how it differs from most of the research being done today in gerontology. He also talks about his own background, and how he came to the field.